C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/00 (2006.01) A61K 38/43 (2006.01) C12N 15/11 (2006.01) C12Q 1/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2380678
The present invention relates to DNAzymes which are targeted against mRNA molecules encoding RelA(p65) (a subunit of NF-.kappa.B).The present invention also relates to compositions including these DNAzymes and to methods of treatment involving administration of the DNAzymes.
La présente invention concerne des DNAzymes qui sont ciblés contre les molécules d'ARN messager codant RelA(p65) (une sous-unité de NF-.kappa.B). Cette invention concerne également des compositions comprenant ces DNAzymes et des procédés de traitement impliquant l'administration de DNAzymes.
Atkins David G.
Cairns Murray John
Handel Malcolm Lovell
Nguyen Ly Quoc Quynh
Johnson & Johnson Research Pty Ltd.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Unisearch Limited
LandOfFree
Treatment of inflammatory or malignant disease using dnazymes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of inflammatory or malignant disease using dnazymes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of inflammatory or malignant disease using dnazymes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1982194